News

Researchers suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, the most common type of kidney cancer
| 3 min read

Researchers suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, the most common type of kidney cancer